Back
Speaker illustration

Doctor Adam Ioannou

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)

Presentations

CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study

Event: EuroEcho-Imaging 2024

Topic: Technology

Session: Late-Breaking Science

Access
Like
Thumbnail

Who, what, where, when, why: imaging and the use of AI in monitoring CA

Event: EuroEcho-Imaging 2024

Topic: Imaging of Heart Failure

Session: A new look at diagnosis, prognosis, and monitoring in cardiac amyloidosis (CA)

Access
Like
Thumbnail

Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Amyloid cardiomyopathy: epidemiology, diagnosis, prognostic and treatment

Access
Like
Thumbnail

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Event: Heart Failure 2023

Topic: Imaging

Session: Cardiac amyloidosis from epidemiology to treatment

Access
Like
Thumbnail

Tracking multi-organ treatment response in systemic AL amyloidosis with cardiac magnetic resonance derived extracellular volume mapping

Event: EACVI 2023

Topic: Myocardial Disease

Session: Young Investigators Award Clinical Cardiology

Access
Like
Thumbnail

Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping

Event: EACVI 2023

Topic: Myocardial Disease

Session: Dechiphering the phenotypes and dynamics of cardiomyopathies under the light of multi-modality imaging

Access
Like
Thumbnail

Automated analysis of echocardiograms at diagnosis is able to predict prognosis in ATTR cardiomyopathy

Event: EACVI 2023

Topic: Myocardial Disease

Session: Cardiac Amyloidosis 1

Access
Like
Thumbnail

Myocardial ischaemia in cardiac amyloidosis: a change of perspective

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: A focus on cardiac amyloidosis

Access
Like
Thumbnail

Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis

Access
Like
Thumbnail

Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years

Event: ESC Congress 2022

Topic: Infiltrative Myocardial Disease

Session: Cardiac amyloidosis: steps ahead

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources